These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 455220

  • 1. Leukocyte migration inhibition assay of tumor immunity in patients with cervical squamous cell carcinoma.
    Rivera ES, Hersh EM, Bowen JM, Barnett JW, Wharton T, Murphy SG.
    Cancer; 1979 Jun; 43(6):2297-305. PubMed ID: 455220
    [No Abstract] [Full Text] [Related]

  • 2. Cell-mediated cytotoxicity in preinvasive and invasive squamous cell carcinoma of the cervix.
    Dini MM, Jafari K, Faiferman I.
    Obstet Gynecol; 1980 Jun; 55(6):728-31. PubMed ID: 7383460
    [Abstract] [Full Text] [Related]

  • 3. Uterine cervical dysplasia & herpes simplex virus.
    Luthra UK, Kotwani BG, Kochhar M, Khurana B, Seth P, Mohapatra LN, Mitra AB, Bhatnagar P, Prabhakar AK, Agarwal SS.
    Indian J Med Res; 1983 Jul; 78 Suppl():60-6. PubMed ID: 6654432
    [No Abstract] [Full Text] [Related]

  • 4. [Cellular immunity in carcinoma of the uterine cervix].
    Pasqualini RS, Giraudo Conesa LC, Chevallier R.
    Medicina (B Aires); 1981 Jul; 41 Suppl():155-60. PubMed ID: 7345340
    [No Abstract] [Full Text] [Related]

  • 5. Relationship of herpes simplex virus type-2 antibodies and squamous dysplasia to cervical carcinoma in situ.
    Thomas DB, Rawls WE.
    Cancer; 1978 Dec; 42(6):2716-25. PubMed ID: 215294
    [Abstract] [Full Text] [Related]

  • 6. Natural killer cell activity in patients with cervical cancer.
    Seth P.
    Indian J Med Res; 1983 Nov; 78():689-93. PubMed ID: 6671715
    [No Abstract] [Full Text] [Related]

  • 7. Cellular hypersensitivity in patients with squamous cell carcinoma of the cervix.
    Chen SS, Koffler D, Cohen CJ.
    Am J Obstet Gynecol; 1975 Jan 01; 121(1):91-5. PubMed ID: 1115121
    [Abstract] [Full Text] [Related]

  • 8. Divergence between the occurrence of antibody and cellular immune reactivity to cervical carcinoma cell lines in preinvasive and macroinvasive stages of cervical carcinoma.
    van de Linde AW, Streefkerk M, Schuurman HJ, te Velde ER, Kater L.
    Br J Cancer; 1983 Jan 01; 47(1):147-53. PubMed ID: 6821628
    [Abstract] [Full Text] [Related]

  • 9. [Immune evaluation of cervical cancer patients--alteration of peripheral lymphocyte subpopulations--(author's transl)].
    Ishiguro T.
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 Jun 01; 32(6):719-24. PubMed ID: 6972426
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Inhibition of leukocyte adherence by potassium chloride extract of allogeneic squamous cell carcinoma of the human uterine cervix.
    Dini MM, Lenzi L, Faiferman I.
    Am J Reprod Immunol (1980); 1983 Jun 01; 3(4):188-90. PubMed ID: 6881415
    [Abstract] [Full Text] [Related]

  • 12. T and B lymphocytes in patients with squamous cell carcinoma of the uterine cervix.
    Ishiguro T, Sugitachi I, Katoh K.
    Gynecol Oncol; 1980 Feb 01; 9(1):80-5. PubMed ID: 6965486
    [No Abstract] [Full Text] [Related]

  • 13. The immunohistological demonstration of carcinoembryonic antigen in intra-epithelial and invasive squamous carcinoma of the cervix.
    McDicken IW, Rainey M.
    Histopathology; 1983 Jul 01; 7(4):475-85. PubMed ID: 6350149
    [Abstract] [Full Text] [Related]

  • 14. Antibody to genital herpes simplex virus: association with cervical atypia and carcinoma in situ.
    Aurelian L, Royston I, Davis HJ.
    J Natl Cancer Inst; 1970 Sep 01; 45(3):455-64. PubMed ID: 4331639
    [No Abstract] [Full Text] [Related]

  • 15. Cell-mediated immunity in patients with ovarian carcinoma.
    Chen SY, Koffler D, Cohen CJ.
    Am J Obstet Gynecol; 1973 Feb 15; 115(4):467-70. PubMed ID: 4346615
    [No Abstract] [Full Text] [Related]

  • 16. A study of herpes simplex type 2 antibody status in groups of patients with cervical neoplasia in Czechoslovakia.
    Janda Z, Kanka J, Vonka V, Svoboda B.
    Int J Cancer; 1973 Nov 15; 12(3):626-30. PubMed ID: 4364794
    [No Abstract] [Full Text] [Related]

  • 17. Rosette formation and inhibition in cervical dysplasia and carcinoma in situ.
    Sawanobori S, Ashman RB, Nahmias AJ, Benigno BB, LaVia MF.
    Cancer Res; 1977 Dec 15; 37(12):4332-5. PubMed ID: 922724
    [Abstract] [Full Text] [Related]

  • 18. Cell-mediated immunity in patients with cervical cancer.
    Cerni C, Tatra G, Berger R, Micksche M.
    Oncology; 1979 Dec 15; 36(4):164-70. PubMed ID: 224356
    [Abstract] [Full Text] [Related]

  • 19. Viruses and gynecologic cancers: herpesvirus protein (ICP 10/AG-4), a cervical tumor antigen that fulfills the criteria for a marker of carcinogenicity.
    Aurelian L, Kessler II, Rosenshein NB, Barbour G.
    Cancer; 1981 Jul 15; 48(2 Suppl):455-71. PubMed ID: 7023662
    [Abstract] [Full Text] [Related]

  • 20. [Genital herpes and cervical cancer].
    Grebeniuk BN, Shuvaeva NI, Grigor'ev VV, Posevaia TA, Shubladze AK.
    Vestn Dermatol Venerol; 1981 Feb 15; (2):9-12. PubMed ID: 6261479
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.